SB 408 Maryland Department of Health Reports on Standing Orders and Opioid Overdose Reversal Drugs
Maryland 2024 Regular Session
Maryland Department of Health - Reports on Standing Orders and Opioid Overdose Reversal Drugs
SB-408
About SB-408
Requiring the Maryland Department of Health to report, on or before December 1, 2024, December 1, 2025, and December 1, 2026, to the Senate Finance Committee and the House Health and Government Operations Committee on current opioid overdose reversal drugs approved by the federal Food and Drug Administration and, for any approved opioid overdose reversal drug, whether the Department has added the drug to a standing order and, if not, the reasons why the drug has not been added.
Bill Texts
Chaptered 05/23/2024
Engrossed 04/02/2024
Introduced 01/18/2024
Weigh In
No votes yet!
Cast yours now to be the first.
Votes for: 0 Votes against: 0
Spread the Word!
Gettr
Sponsors (1)
